BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nordenbaek C, Johansen JS, Junker P, Borregaard N, Sørensen O, Price PA. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 1999;180:1722-6. [PMID: 10515841 DOI: 10.1086/315050] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Eurich K, Segawa M, Toei-Shimizu S, Mizoguchi E. Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 2009; 15(42): 5249-5259 [PMID: 19908331 DOI: 10.3748/wjg.15.5249] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
2 Dehn H, Høgdall EVS, Johansen JS, Jørgensen M, Price PA, Engelholm SAA, Høgdall CK. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer: YKL-40 and ovarian cancer. Acta Obstetricia et Gynecologica Scandinavica 2003;82:287-93. [DOI: 10.1034/j.1600-0412.2003.00010.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
3 Kyrgios I, Galli-Tsinopoulou A, Stylianou C, Papakonstantinou E, Arvanitidou M, Haidich AB. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism 2012;61:562-8. [PMID: 22036069 DOI: 10.1016/j.metabol.2011.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
4 Wang HL, Hsiao PC, Tsai HT, Yeh CB, Yang SF. Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients. Int J Mol Sci 2013;14:22817-25. [PMID: 24256818 DOI: 10.3390/ijms141122817] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
5 Kjaergaard AD, Helby J, Johansen JS, Nordestgaard BG, Bojesen SE. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. Clin Microbiol Infect 2020;26:1411.e1-9. [PMID: 31972315 DOI: 10.1016/j.cmi.2020.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Klausen P, Niemann CU, Cowland JB, Krabbe K, Borregaard N. On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur J Haematol 2005;75:332-40. [PMID: 16146540 DOI: 10.1111/j.1600-0609.2005.00511.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
7 Nøjgaard C, Høst NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA, Johansen JS. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 2008;19:257-63. [PMID: 18480670 DOI: 10.1097/MCA.0b013e3282f40dd5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
8 Kanazawa J, Kitazawa H, Masuko H, Yatagai Y, Sakamoto T, Kaneko Y, Iijima H, Naito T, Saito T, Noguchi E, Konno S, Nishimura M, Hirota T, Tamari M, Hizawa N. A cis-eQTL allele regulating reduced expression of CHI3L1 is associated with late-onset adult asthma in Japanese cohorts. BMC Med Genet 2019;20:58. [PMID: 30940096 DOI: 10.1186/s12881-019-0786-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bissel SJ, Kofler J, Nyaundi J, Murphey-Corb M, Wisniewski SR, Wiley CA. Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis. J Neuroimmune Pharmacol 2016;11:332-47. [PMID: 27059917 DOI: 10.1007/s11481-016-9666-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Johansen JS, Krabbe KS, Møller K, Pedersen BK. Circulating YKL-40 levels during human endotoxaemia. Clin Exp Immunol. 2005;140:343-348. [PMID: 15807860 DOI: 10.1111/j.1365-2249.2005.02763.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
11 Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer. 2002;95:267-274. [PMID: 12124825 DOI: 10.1002/cncr.10644] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 4.6] [Reference Citation Analysis]
12 Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da Silva CA, Sohn MH, Cohn L, Homer RJ, Kozhich AA. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009;206:1149-1166. [PMID: 19414556 DOI: 10.1084/jem.20081271] [Cited by in Crossref: 275] [Cited by in F6Publishing: 278] [Article Influence: 21.2] [Reference Citation Analysis]
13 Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223-231. [PMID: 15829322 DOI: 10.1016/j.lungcan.2004.11.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
14 Kzhyshkowska J, Gratchev A, Goerdt S. Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer. Biomark�Insights 2007;2:117727190700200. [DOI: 10.1177/117727190700200023] [Cited by in Crossref: 115] [Cited by in F6Publishing: 51] [Article Influence: 23.0] [Reference Citation Analysis]
15 Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009;511:159-84. [PMID: 19347297 DOI: 10.1007/978-1-59745-447-6_7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
16 Xing S, Zheng X, Zeng T, Zeng MS, Zhong Q, Cao YS, Pan KL, Wei C, Hou F, Liu WL. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World J Gastroenterol 2017; 23(43): 7693-7704 [PMID: 29209110 DOI: 10.3748/wjg.v23.i43.7693] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 Lee CG, Dela Cruz CS, Ma B, Ahangari F, Zhou Y, Halaban R, Sznol M, Elias JA. Chitinase-like proteins in lung injury, repair, and metastasis. Proc Am Thorac Soc 2012;9:57-61. [PMID: 22550243 DOI: 10.1513/pats.201112-056MS] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
18 Breyne K, Steenbrugge J, Demeyere K, Lee CG, Elias JA, Petzl W, Smith DGE, Germon P, Meyer E. Immunomodulation of Host Chitinase 3-Like 1 During a Mammary Pathogenic Escherichia coli Infection. Front Immunol 2018;9:1143. [PMID: 29892291 DOI: 10.3389/fimmu.2018.01143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? Respir Med. 2005;99:396-402. [PMID: 15763444 DOI: 10.1016/j.rmed.2004.09.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
20 Schmalenberg M, Beaudoin C, Bulst L, Steubl D, Luppa PB. Magnetic bead fluorescent immunoassay for the rapid detection of the novel inflammation marker YKL40 at the point-of-care. Journal of Immunological Methods 2015;427:36-41. [DOI: 10.1016/j.jim.2015.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Kamle S, Ma B, He CH, Akosman B, Zhou Y, Lee CM, El-Deiry WS, Huntington K, Liang O, Machan JT, Kang MJ, Shin HJ, Mizoguchi E, Lee CG, Elias JA. Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. JCI Insight 2021;6:e148749. [PMID: 34747367 DOI: 10.1172/jci.insight.148749] [Reference Citation Analysis]
22 Breyne K, Steenbrugge J, Demeyere K, Vanden Berghe T, Meyer E. Preconditioning with Lipopolysaccharide or Lipoteichoic Acid Protects against Staphylococcus aureus Mammary Infection in Mice. Front Immunol 2017;8:833. [PMID: 28791009 DOI: 10.3389/fimmu.2017.00833] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
23 Santos CB, Davidson J, Covar RA, Spahn JD. The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children. Ann Allergy Asthma Immunol 2014;113:263-6. [PMID: 24954373 DOI: 10.1016/j.anai.2014.05.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
24 Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003;80:15-21. [PMID: 12889595 DOI: 10.1023/A:1024431000710] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
25 Ringsholt M, Høgdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007;38:33-43. [PMID: 17242979 DOI: 10.1007/s10735-006-9075-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
26 Jeon SH, Lee YS, Yeo IJ, Lee HP, Yoon J, Son DJ, Han SB, Hong JT. Inhibition of Chitinase-3-like-1 by K284-6111 Reduces Atopic Skin Inflammation via Repressing Lactoferrin. Immune Netw 2021;21:e22. [PMID: 34277112 DOI: 10.4110/in.2021.21.e22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Kaynar MY, Tanriverdi T, Kafadar AM, Kacira T, Yurdakul F, Uzun H, Gumustas K. YKL-40 levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: preliminary results. J Clin Neurosci 2005;12:754-7. [PMID: 16153848 DOI: 10.1016/j.jocn.2005.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
28 Vignon É. Is glycoprotein YKL40 a new marker for joint disorders? Joint Bone Spine 2001;68:454-6. [DOI: 10.1016/s1297-319x(01)00307-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Okyay GU, Er RE, Tekbudak MY, Paşaoğlu Ö, İnal S, Öneç K, Paşaoğlu H, Altok K, Derici Ü, Erten Y. Novel Inflammatory Marker in Dialysis Patients: YKL-40: YKL-40 in Dialysis Patients. Ther Apher Dial 2013;17:193-201. [DOI: 10.1111/j.1744-9987.2012.01141.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 Keskin GS, Helvacı Ö, Yayla Ç, Paşaoğlu Ö, Keskin Ç, Arınsoy T, Derici Ü. Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease. Turk J Med Sci 2019;49:139-46. [PMID: 30763987 DOI: 10.3906/sag-1804-169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Muszyński P, Groblewska M, Kulczyńska-Przybik A, Kułakowska A, Mroczko B. YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease. Curr Neuropharmacol 2017;15:906-17. [PMID: 28183245 DOI: 10.2174/1570159X15666170208124324] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
32 Li W, Yu Z, Jiang C. Association of Serum YKL-40 With the Presence and Severity of Obstructive Sleep Apnea Syndrome. Lab Med 2014;45:220-5. [DOI: 10.1309/lms98akcxrsl2xor] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Rath T, Zwaschka L, Hage L, Kügler M, Menendez K, Naehrlich L, Schulz R, Roderfeld M, Roeb E. Identification of neutrophil activation markers as novel surrogate markers of CF lung disease. PLoS One 2014;9:e115847. [PMID: 25545245 DOI: 10.1371/journal.pone.0115847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
34 James A, Stenberg Hammar K, Reinius L, Konradsen JR, Dahlén SE, Söderhäll C, Hedlin G. A longitudinal assessment of circulating YKL-40 levels in preschool children with wheeze. Pediatr Allergy Immunol 2017;28:79-85. [PMID: 27732738 DOI: 10.1111/pai.12669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
35 Kim HR, Jun CD, Lee KS, Cho JH, Jeong ET, Yang SH, Lee YJ, Park DS. Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease. Cytokine 2012;58:336-43. [PMID: 22480951 DOI: 10.1016/j.cyto.2012.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
36 Conroy AL, Gélvez M, Hawkes M, Rajwans N, Tran V, Liles WC, Villar-Centeno LA, Kain KC. Host biomarkers are associated with progression to dengue haemorrhagic fever: a nested case-control study. Int J Infect Dis 2015;40:45-53. [PMID: 26255888 DOI: 10.1016/j.ijid.2015.07.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
37 Allin KH, Bojesen SE, Johansen JS, Nordestgaard BG. Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population. Br J Cancer 2012;106:199-205. [PMID: 22095223 DOI: 10.1038/bjc.2011.501] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
38 Hattori N, Oda S, Sadahiro T, Nakamura M, Abe R, Shinozaki K, Nomura F, Tomonaga T, Matsushita K, Kodera Y, Sogawa K, Satoh M, Hirasawa H. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 2009;32:393-400. [PMID: 19197227 DOI: 10.1097/SHK.0b013e31819e2c0c] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
39 Liu L, Zhang X, Liu Y, Zhang L, Zheng J, Wang J, Hansbro PM, Wang L, Wang G, Hsu AC. Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations. Respir Res 2019;20:95. [PMID: 31113430 DOI: 10.1186/s12931-019-1051-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
40 Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P, Fan H. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review. Int J Chron Obstruct Pulmon Dis 2018;13:409-18. [PMID: 29430175 DOI: 10.2147/COPD.S152655] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
41 Johansen JS, Jensen BV, Roslind A, Price PA. Is YKL-40 a new therapeutic target in cancer? Expert Opinion on Therapeutic Targets 2007;11:219-34. [DOI: 10.1517/14728222.11.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
42 Mansell J, Cooke M, Read M, Rudd H, Shiel A, Wilkins K, Manso M. Chitinase 3-like 1 expression by human (MG63) osteoblasts in response to lysophosphatidic acid and 1,25-dihydroxyvitamin D3. Biochimie 2016;128-129:193-200. [DOI: 10.1016/j.biochi.2016.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lee JH, Kim SS, Kim IJ, Song SH, Kim YK, In Kim J, Jeon YK, Kim BH, Kwak IS. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients. J Diabetes Complications. 2012;26:308-312. [PMID: 22705282 DOI: 10.1016/j.jdiacomp.2012.04.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
44 Wittenhagen P, Kronborg G, Weis N, Nielsen H, Obel N, Pedersen S, Eugen-olsen J. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clinical Microbiology and Infection 2004;10:409-15. [DOI: 10.1111/j.1469-0691.2004.00850.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 5.5] [Reference Citation Analysis]
45 Höbaus C, Tscharre M, Herz CT, Pesau G, Wrba T, Koppensteiner R, Schernthaner GH. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients. Atherosclerosis 2018;274:152-6. [PMID: 29783062 DOI: 10.1016/j.atherosclerosis.2018.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Jafary F, Khamechi SP, Talari HR, Sharif MR, Nikoueinejad H, Sehhat M. Correlation between serum YKL-40 and carotid intima media thickness in type 1 diabetics. Int J Diabetes Dev Ctries 2015;35:411-7. [DOI: 10.1007/s13410-015-0363-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Huang K, Wu LD. YKL-40: a potential biomarker for osteoarthritis. J Int Med Res 2009;37:18-24. [PMID: 19215669 DOI: 10.1177/147323000903700102] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
48 Thöm I, Andritzky B, Schuch G, Burkholder I, Edler L, Johansen JS, Bokemeyer C, Schumacher U, Laack E. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer 2010;116:4114-21. [PMID: 20564116 DOI: 10.1002/cncr.25196] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
49 Kacira T, Hanimoglu H, Kucur M, Sanus GZ, Kafadar AM, Tanriverdi T, Kaynar MY. Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2008;15:1011-6. [PMID: 18280741 DOI: 10.1016/j.jocn.2006.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
50 Erdman LK, D'Acremont V, Hayford K, Rajwans N, Kilowoko M, Kyungu E, Hongoa P, Alamo L, Streiner DL, Genton B, Kain KC. Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study. PLoS One 2015;10:e0137592. [PMID: 26366571 DOI: 10.1371/journal.pone.0137592] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
51 Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008;45:531-562. [PMID: 19003601 DOI: 10.1080/10408360802334743] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
52 De Loor J, Decruyenaere J, Demeyere K, Nuytinck L, Hoste EA, Meyer E. Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients. Crit Care 2016;20:38. [PMID: 26864834 DOI: 10.1186/s13054-016-1192-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
53 Schultz NA, Johansen JS. YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Cancers (Basel) 2010;2:1453-91. [PMID: 24281168 DOI: 10.3390/cancers2031453] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
54 Ober C, Chupp GL. The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr Opin Allergy Clin Immunol 2009;9:401-8. [PMID: 19644363 DOI: 10.1097/ACI.0b013e3283306533] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
55 Spoorenberg SMC, Vestjens SMT, Voorn GP, van Moorsel CHM, Meek B, Zanen P, Rijkers GT, Bos WJW, Grutters JC; Ovidius study group. Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis. PLoS One 2018;13:e0190575. [PMID: 29324810 DOI: 10.1371/journal.pone.0190575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Alamili M, Bendtzen K, Lykkesfeldt J, Rosenberg J, Gögenur I. Pronounced inflammatory response to endotoxaemia during nighttime: a randomised cross-over trial. PLoS One 2014;9:e87413. [PMID: 24475284 DOI: 10.1371/journal.pone.0087413] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
57 Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479-501. [PMID: 21054166 DOI: 10.1146/annurev-physiol-012110-142250] [Cited by in Crossref: 471] [Cited by in F6Publishing: 471] [Article Influence: 42.8] [Reference Citation Analysis]
58 Nordenbaek C, Teisner B, Junker P. Connective tissue responses in acute community-acquired pneumonia. Respir Med 2003;97:660-6. [PMID: 12814151 DOI: 10.1053/rmed.2003.1497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Schmidt H, Johansen JS, Gehl J, Geertsen PF, Fode K, von der Maase H. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer. 2006;106:1130-1139. [PMID: 16456816 DOI: 10.1002/cncr.21678] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 5.4] [Reference Citation Analysis]
60 Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011;10:742-51. [PMID: 21357475 DOI: 10.1158/1535-7163.MCT-10-0868] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 9.0] [Reference Citation Analysis]
61 Otterdal K, Janardhanan J, Astrup E, Ueland T, Prakash JA, Lekva T, Abraham OC, Thomas K, Damås JK, Mathews P, Mathai D, Aukrust P, Varghese GM. Increased endothelial and macrophage markers are associated with disease severity and mortality in scrub typhus. J Infect 2014;69:462-9. [PMID: 24995849 DOI: 10.1016/j.jinf.2014.06.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
62 Erdman LK, Petes C, Lu Z, Dhabangi A, Musoke C, Cserti-Gazdewich CM, Lee CG, Liles WC, Elias JA, Kain KC. Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African children. Malar J 2014;13:279. [PMID: 25047113 DOI: 10.1186/1475-2875-13-279] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
63 Lai T, Wu D, Chen M, Cao C, Jing Z, Huang L, Lv Y, Zhao X, Lv Q, Wang Y, Li D, Wu B, Shen H. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res 2016;17:31. [PMID: 27013031 DOI: 10.1186/s12931-016-0338-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
64 Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau MO, Battu S, Lalloué F. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget 2016;7:50349-64. [PMID: 27385098 DOI: 10.18632/oncotarget.10387] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
65 Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002;9:598-604. [PMID: 11986266 DOI: 10.1128/cdli.9.3.598-604.2002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 35] [Article Influence: 0.5] [Reference Citation Analysis]
66 Thongsom S, Chaocharoen W, Silsirivanit A, Wongkham S, Sripa B, Choe H, Suginta W, Talabnin C. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Tumour Biol. 2016;37:9451-9463. [PMID: 26781979 DOI: 10.1007/s13277-016-4838-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
67 Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urologic Oncology: Seminars and Original Investigations 2014;32:663-9. [DOI: 10.1016/j.urolonc.2014.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
68 Lee CG, Elias JA. Role of breast regression protein-39/YKL-40 in asthma and allergic responses. Allergy Asthma Immunol Res 2010;2:20-7. [PMID: 20224674 DOI: 10.4168/aair.2010.2.1.20] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
69 Zhu CB, Chen LL, Tian JJ, Su L, Wang C, Gai ZT, Du WJ, Ma GL. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery. Ann Surg Oncol. 2012;19:817-825. [PMID: 21861215 DOI: 10.1245/s10434-011-2026-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
70 Deutschmann C, Roggenbuck D, Schierack P. The loss of tolerance to CHI3L1 – A putative role in inflammatory bowel disease? Clinical Immunology 2019;199:12-7. [DOI: 10.1016/j.clim.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
71 Leth-larsen R, Nordenbaek C, Tornoe I, Moeller V, Schlosser A, Koch C, Teisner B, Junker P, Holmskov U. Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia☆☆This work was supported by the Danish Medical Research Council, an EU grant, contract number: QLK2-CT-2000-0035; the Novo Nordisk Foundation; Fonden til Lægevidenskabens Fremme; Ingemann O. Bucks Foundation and the Benzon Foundation. Clinical Immunology 2003;108:29-37. [DOI: 10.1016/s1521-6616(03)00042-1] [Cited by in Crossref: 82] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
72 Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine. 2011;55:152-155. [PMID: 21478032 DOI: 10.1016/j.cyto.2011.03.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
73 Kros JM, Mustafa DM, Dekker LJ, Sillevis Smitt PA, Luider TM, Zheng PP. Circulating glioma biomarkers. Neuro Oncol 2015;17:343-60. [PMID: 25253418 DOI: 10.1093/neuonc/nou207] [Cited by in Crossref: 25] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
74 Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Science 2005;96:183-90. [DOI: 10.1111/j.1349-7006.2005.00026.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
75 Wygrecka M, Schaefer L. Between life and death: Epithelial cells in lung pathologies. Cell Signal 2020;72:109652. [PMID: 32325184 DOI: 10.1016/j.cellsig.2020.109652] [Reference Citation Analysis]
76 Dela Cruz CS, Liu W, He CH, Jacoby A, Gornitzky A, Ma B, Flavell R, Lee CG, Elias JA. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe. 2012;12:34-46. [PMID: 22817986 DOI: 10.1016/j.chom.2012.05.017] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
77 Kido J, Bando Y, Bando M, Kajiura Y, Hiroshima Y, Inagaki Y, Murata H, Ikuta T, Kido R, Naruishi K, Funaki M, Nagata T. YKL-40 level in gingival crevicular fluid from patients with periodontitis and type 2 diabetes. Oral Dis. 2015;21:667-673. [PMID: 25740558 DOI: 10.1111/odi.12334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
78 Wang F, Li W, Liu Z, Yu R, Wang D. LPS-induced inflammatory response and apoptosis are mediated by Fra-1 upregulation and binding to YKL-40 in A549 cells. Exp Ther Med 2021;22:1474. [PMID: 34737814 DOI: 10.3892/etm.2021.10909] [Reference Citation Analysis]
79 Lieder R, Thormodsson F, Ng CH, Einarsson JM, Gislason J, Petersen PH, Sigurjonsson OE. Chitosan and Chitin Hexamers affect expansion and differentiation of mesenchymal stem cells differently. Int J Biol Macromol 2012;51:675-80. [PMID: 22790025 DOI: 10.1016/j.ijbiomac.2012.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
80 Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol 2009;5:1065-82. [PMID: 19792974 DOI: 10.2217/fon.09.66] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 7.4] [Reference Citation Analysis]
81 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci 2016;53:396-408. [PMID: 27187575 DOI: 10.1080/10408363.2016.1190683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]